Lepu Biopharma (乐普生物科技) IPO: Sentiment Cooled Down
Downsized deal amid cooled sentiment for Chapter 18A, we think the valuation of Lepu Biopharm is not attractive for investors.
411 Views
Lepu Biopharma IPO: PHIP Updates
Lepu Biopharma (LBP HK) is a biopharmaceutical company focusing on oncology therapeutics. In this follow-up insight, we have highlighted new data...
479 Views
Lepu Biopharma IPO: No Monetisation Timeline in Sight
Lepu has a strong product portfolio with most of its products displaying a strong competitive advantage. However, the company is yet to generate...
547 Views
Keymed Biosciences (2162.HK) - The Pipeline, the Concerns on Valuation Growth & The Trading Strategy
This article mainly analyzed Keymed in terms of the business, the core and key candidates in the pipeline, the concerns about valuation growth...
407 Views
ECM Weekly (12th December 2021) - LG Energy, SenseTime (Delayed), Didi, Kanzhun & Full Truck Lock-Up
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
488 Views